Korean Circ J.  2007 Dec;37(12):609-615. 10.4070/kcj.2007.37.12.609.

Risk Factors for Predicting New-Onset Atrial Fibrillation in Persons Who Received Health Screening Tests

• Kim HJ
• On YK
• Sung J
• Kim JH
• Song YB
• Lee WS
• Choi JO
• Shin DH
• Cho SW
• Choi JH
• Hahn JY
• Kim JS

• KMID: 2227035
• DOI: http://doi.org/10.4070/kcj.2007.37.12.609

Abstract

BACKGROUND AND OBJECTIVES: Atrial fibrillation (AF) is the most common significant arrhythmia in the general population, and it is associated with increased cardiovascular morbidity and mortality. The incidence of and the risk factors for new-onset AF have not been well evaluated in Koreans.
SUBJECTS AND METHODS
We retrospectively analyzed 16,568 adults (median age 49 years, 10,685 males and 5,883 females) who had repeatedly received screening tests for general health at the Health Promotion Center, Samsung Medical Center in Korea between March, 2001 and June, 2006 (mean follow up duration: 44 months).
RESULTS
Sixty one cases had new-onset AF noted on the electrocardiogram (ECG). On the univariate analysis, age, male gender, a history of coronary artery disease and taking hypertension medication, the waist circumference, body mass index, fasting glucose, hemoglobin A1c, fibrinogen, and left atrium enlargement seen on ECG at baseline were significantly associated with new-onset AF. After multivariable adjustment, the independent risk factors for predicting new-onset AF were male gender [odds ratio (OR): 3.356, 95% confidence interval (CI): 1.168-9.643, p=0.025] and a history of coronary artery disease (OR: 4.657, 95% CI: 1.703-12.737, p=0.003).
CONCLUSION
The risk factors for predicting new-onset AF in persons who received general health screening tests were male gender and a history of coronary artery disease.

Keyword

Atrial fibrillation; Risk factor

MeSH Terms

Adult
Arrhythmias, Cardiac
Atrial Fibrillation*
Body Mass Index
Coronary Artery Disease
Electrocardiography
Fasting
Fibrinogen
Follow-Up Studies
Glucose
Health Promotion
Heart Atria
Humans
Hypertension
Incidence
Korea
Male
Mass Screening*
Mortality
Retrospective Studies
Risk Factors*
Waist Circumference
Fibrinogen
Glucose

Reference

1. Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI. A survey of atrial fibrillation in general practice. Br J Gen Pract. 1997. 47:285–289.

2. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998. 82:2N–9N.

3. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation. Circulation. 2004. 110:1042–1046.

4. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995. 155:469–473.

5. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997. 96:2455–2461.

6. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention. JAMA. 2001. 285:2370–2375.

7. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart. 2001. 86:284–288.

8. Ruigomez A, Johansson S, Wallander MA, Rodriguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol. 2002. 55:358–363.

9. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. JAMA. 1994. 271:840–844.

10. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995. 98:476–484.

11. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001. 86:516–521.

12. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation. Eur Heart J. 2006. 27:949–953.

13. Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med. 2001. 250:382–389.

14. Lee SM, Choue CW, Hong SJ, et al. The joint multicenter study on the atrial fibrillation in Korea. Korean Circ J. 2000. 30:646–652.

15. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006. 368:1681–1688.

16. Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment and control of hypertension in China. Hypertension. 2002. 40:920–927.

17. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. Circulation. 1994. 89:724–730.

18. Yamada T, Fukunami M, Shimonagata T, et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. J Am Coll Cardiol. 2000. 35:405–413.

19. Cho KI, Lee HG, Ak SJ, et al. Quantitative assessment of left atrial functional changes in patients with atrial fibrillation by tissue doppler strain and 2-dimensional strain imaging. Korean Circ J. 2006. 36:786–793.

20. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004. 292:2471–2477.

21. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005. 118:489–495.

22. Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation. 2005. 112:3247–3255.

23. Frost L, Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med. 2004. 164:1993–1998.

24. Mukamal KJ, Tolstrup JS, Friberg J, Jensen G, Grønbæk M. Alcohol consumption and risk of atrial fibrillation in men and women. Circulation. 2005. 112:1736–1742.

25. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003. 108:3006–3010.

26. Hwang SJ, Sung KC, Lee YS, et al. Serum C-reactive protein level and its association with atrial fibrillation in Korean adults. Korean Circ J. 2005. 35:309–314.

27. Mukamal KJ, Tolstrup JS, Friberg J, Grønbaek M, Jensen G. Fibrinogen and albumin levels and risk of atrial fibrillation in men and woman. Am J Cardiol. 2006. 98:75–81.

28. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994. 331:1249–1252.

29. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J. 2001. 142:838–842.